---
schema_version: "secwatch.filing_event.v1"
accession: "0001798749-24-000033"
form_type: "8-K"
ticker: "JBIO"
cik: "0001798749"
company_name: "Jade Biosciences, Inc."
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:39:17.651437+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Aerovate Therapeutics stockholders elect directors and ratify KPMG as auditor at 2024 annual meeting

## Summary
- Stockholders elected David Grayzel, M.D. and Maha Katabi, Ph.D. as Class III directors with 24.4M and 25.9M votes for, respectively.
- Ratification of KPMG LLP as independent auditor for FY 2024 was approved with 28,074,033 votes for, 511 against, 105 abstain.
- The meeting was held on June 5, 2024; 28,737,381 shares were outstanding and entitled to vote as of April 12, 2024 record date.

## SEC filing metadata
- accession: 0001798749-24-000033
- form_type: 8-K
- ticker: JBIO
- cik: 0001798749
- company_name: Jade Biosciences, Inc.
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1798749/000179874924000033/0001798749-24-000033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1798749/000179874924000033/tmb-20240605x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001798749-24-000033
- JSON: https://secwatch.observer/filing/0001798749-24-000033.json
- Plain text: https://secwatch.observer/filing/0001798749-24-000033.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.